PCR-Based_JJ Identification_NN of_IN Bacteria_NP Associated_NP with_IN Endodontic_NP Infections_NP PCR_NP primers_NNS that_WDT target_VBP the_DT bacterial_JJ 16S_JJ rRNA_NN genes_NNS (_( or_CC the_DT tuf_NN gene_NN for_IN the_DT genus_NN Enterococcus_NN )_) were_VBD used_VBN to_TO identify_VB 10_CD putative_JJ bacterial_JJ pathogens_NNS in_IN root_NN canals_NNS with_IN necrotic_JJ pulp_NN ._SENT In_IN addition_NN ,_, the_DT associations_NNS of_IN these_DT microorganisms_NNS with_IN symptoms_NNS and_CC a_DT history_NN of_IN diabetes_NN mellitus_NNS were_VBD investigated_VBN ._SENT Microbial_JJ samples_NNS from_IN the_DT root_NN canals_NNS of_IN 24_CD teeth_NNS with_IN necrotic_JJ pulp_NN were_VBD included_VBN in_IN the_DT study_NN ._SENT PCR_NP with_IN universal_JJ bacterial_JJ primers_NNS identified_VBD bacterial_JJ DNA_NN in_IN 22_CD specimens_NNS ;_: the_DT remaining_VBG 2_CD specimens_NNS were_VBD from_IN intact_JJ teeth_NNS that_WDT had_VBD been_VBN traumatized_VBN 6_CD months_NNS prior_RB to_TO treatment_NN ._SENT PCR_NP with_IN specific_JJ primers_NNS showed_VBD that_IN preoperative_JJ symptoms_NNS were_VBD significantly_RB associated_VBN with_IN the_DT presence_NN of_IN Streptococcus_NP spp._NP (_( P_NN <_0.001 2_CD )_) and_CC for_IN diabetes_NN mellitus_NN to_TO be_VB associated_VBN with_IN P._NP gingivalis_NP and_CC Porphyromonas_NP endodontalis_NNS (_( odds_NNS ratio_NN ,_, >2_JJ )_) ._SENT Cloning_VBG and_CC sequencing_VBG of_IN the_DT universal_JJ PCR_NP product_NN in_IN one_CD specimen_NN revealed_VBD the_DT presence_NN of_IN an_DT organism_NN related_VBN to_TO the_DT genus_NN Olsenella_NP ,_, which_WDT has_VBZ not_RB previously_RB been_VBN described_VBN in_IN endodontic_JJ infections_NNS ._SENT The_DT presence_NN of_IN bacteria_NNS in_IN the_DT root_NN canal_NN leads_VBZ to_TO the_DT development_NN of_IN periapical_JJ periodontitis_NN ._SENT Several_JJ studies_NNS have_VBP shown_VBN an_DT association_NN between_IN painful_JJ exacerbation_NN of_IN periapical_JJ lesions_NNS and_CC the_DT presence_NN in_IN the_DT root_NN canal_NN of_IN specific_JJ bacteria_NNS ._SENT Black-pigmented_JJ bacteria_NNS belonging_VBG to_TO the_DT genera_NNS Porphyromonas_NP ,_, Prevotella_NP ,_, and_CC Bacteroides_NP have_VBP been_VBN cultured_VBN from_IN root_NN canals_NNS in_IN a_DT significant_JJ proportion_NN of_IN cases_NNS in_IN those_DT studies_NNS and_CC are_VBP frequently_RB present_JJ in_IN the_DT same_JJ canals_NNS as_IN members_NNS of_IN the_DT genera_NNS Peptostreptococcus_NP and_CC Fusobacterium_NP ._SENT However_RB ,_, the_DT findings_NNS of_IN different_JJ studies_NNS based_VBN on_IN culturing_VBG of_IN canal_NN contents_NNS vary_VBP significantly_RB ._SENT This_DT may_MD be_VB due_JJ ,_, at_IN least_JJS in_IN part_NN ,_, to_TO the_DT reduced_VBN reliability_NN and_CC sensitivity_NN of_IN culturing_VBG techniques_NNS ._SENT The_DT persistence_NN or_CC further_JJR expansion_NN of_IN a_DT periapical_JJ lesion_NN ,_, despite_IN seemingly_RB adequate_JJ endodontic_JJ treatment_NN and_CC timely_JJ restoration_NN of_IN the_DT tooth_NN ,_, is_VBZ usually_RB attributed_VBN to_TO the_DT persistence_NN of_IN pathogenic_JJ microorganisms_NNS in_IN the_DT root_NN canal_NN system_NN ._SENT Recent_JJ investigations_NNS have_VBP documented_VBN that_IN the_DT presence_NN of_IN cultivable_JJ bacteria_NNS from_IN canals_NNS at_IN the_DT time_NN of_IN obturation_NN was_VBD critical_JJ in_IN predicting_VBG failure_NN of_IN treatment_NN ._SENT However_RB ,_, the_DT microorganisms_NNS most_RBS commonly_RB associated_VBN with_IN failed_JJ endodontic_JJ cases_NNS are_VBP different_JJ from_IN those_DT cultured_VBN from_IN canals_NNS with_IN pulp_NN necrosis_NN ._SENT Studies_NNS reveal_VBP that_IN most_JJS of_IN these_DT failed_JJ cases_NNS have_VBP gram-positive_JJ strains_NNS such_JJ as_IN enterococci_NNS ,_, streptococci_NNS ,_, and_CC eubacteria_NN ,_, with_IN occasional_JJ Candida_NP ,_, peptostreptococci_NP ,_, and_CC fusobacteria_NNS ._SENT Although_IN enterococci_NP were_VBD the_DT most_RBS prevalent_JJ microorganisms_NNS in_IN the_DT last_JJ three_CD studies_NNS ,_, being_VBG present_JJ in_IN 54_CD ,_, 70_CD ,_, and_CC 38_CD %_NN of_IN the_DT cases_NNS ,_, respectively_RB ,_, the_DT percentages_NNS of_IN different_JJ strains_NNS identified_VBD again_RB vary_VB significantly_RB among_IN the_DT studies_NNS ,_, and_CC in_IN a_DT considerable_JJ number_NN of_IN cases_NNS there_EX were_VBD no_DT cultivable_JJ microorganisms_NNS ._SENT Therefore_RB ,_, sensitive_JJ and_CC accurate_JJ molecular_JJ techniques_NNS are_VBP necessary_JJ to_TO accurately_RB characterize_VB the_DT root_NN canal_NN microbial_JJ irritants_NNS in_IN order_NN to_TO determine_VB their_PP$ association_NN with_IN clinical_JJ symptoms_NNS and_CC the_DT prognosis_NN of_IN treatment_NN ._SENT For_IN example_NN ,_, the_DT introduction_NN of_IN molecular_JJ methods_NNS into_IN analyses_NNS of_IN root_NN canal_NN samples_NNS has_VBZ led_VBN to_TO the_DT identification_NN of_IN a_DT number_NN of_IN fastidious_JJ organisms_NNS such_JJ as_IN Bacteroides_NP forsythus_NP and_CC Treponema_NP denticola_NP ,_, which_WDT have_VBP not_RB previously_RB been_VBN described_VBN in_IN endodontic_JJ infections_NNS ._SENT PCR_NP amplification_NN of_IN the_DT bacterial_JJ 16S_JJ or_CC 23S_JJ rRNA_NN gene_NN (_( rDNA_NN )_) or_CC other_JJ rDNAs_NNS is_VBZ more_RBR sensitive_JJ and_CC more_RBR efficient_JJ than_IN culturing_VBG and_CC biochemical_JJ identification_NN of_IN endodontic_JJ flora_NN ._SENT In_IN the_DT root_NN canal_NN microbial_JJ environment_NN ,_, PCR_NP was_VBD shown_VBN to_TO be_VB more_RBR accurate_JJ than_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN in_IN differentiating_VBG and_CC identifying_VBG the_DT two_CD important_JJ endodontic_JJ pathogens_NNS ,_, Prevotella_NP intermedia_NP and_CC Prevotella_NP nigrescens_NNS ,_, which_WDT could_MD not_RB be_VB differentiated_VBN by_IN culturing_VBG ._SENT Although_IN the_DT use_NN of_IN DNA_NN probes_NNS can_MD be_VB more_RBR sensitive_JJ and_CC more_RBR efficient_JJ than_IN culturing_VBG ,_, it_PP still_RB requires_VBZ the_DT presence_NN of_IN >104_JJ bacterial_JJ cells_NNS to_TO ensure_VB detection_NN ._SENT The_DT PCR_NP technique_NN can_MD be_VB sensitive_JJ enough_RB to_TO detect_VB a_DT few_JJ DNA_NN strands_NNS of_IN the_DT microorganisms_NNS present_JJ if_IN adequate_JJ primers_NNS are_VBP used_VBN and_CC the_DT PCR_NP conditions_NNS are_VBP sufficiently_RB optimized_VBN ._SENT We_PP have_VBP recently_RB shown_VBN that_IN ,_, after_IN inoculation_NN of_IN three_CD endodontopathogenic_JJ bacteria_NNS in_IN mouse_NN pulp_NN exposures_NNS ,_, PCR_NP was_VBD much_RB more_RBR accurate_JJ than_IN culturing_VBG in_IN detecting_VBG the_DT inoculated_VBN anaerobic_JJ bacteria_NNS ._SENT Several_JJ uncultivable_JJ species_NNS have_VBP been_VBN identified_VBN from_IN dentoalveolar_JJ abscesses_NNS by_IN PCR_NP ._SENT Previous_JJ studies_NNS have_VBP shown_VBN that_IN the_DT diabetic_JJ host_NN may_MD have_VB an_DT increased_VBN periapical_JJ lesion_NN size_NN or_CC may_MD develop_VB more_RBR serious_JJ infections_NNS in_IN response_NN to_TO virulent_JJ root_NN canal_NN bacteria_NNS ._SENT Patients_NNS with_IN a_DT history_NN of_IN diabetes_NN mellitus_NN and_CC periapical_JJ lesions_NNS may_MD have_VB significantly_RB reduced_VBN healing_NN following_VBG endodontic_JJ therapy_NN compared_VBN with_IN that_DT for_IN the_DT nondiabetic_JJ population_NN ._SENT The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO determine_VB the_DT presence_NN of_IN 10_CD putative_JJ root_NN canal_NN microorganisms_NNS in_IN samples_NNS from_IN root_NN canals_NNS with_IN necrotic_JJ pulp_NN and_CC apical_JJ periodontitis_NN by_IN using_VBG universal_JJ bacterial_JJ as_RB well_RB as_IN species-_NN or_CC genus-specific_JJ PCR_NP primers_NNS ._SENT We_PP also_RB determined_VBD the_DT association_NN of_IN these_DT organisms_NNS with_IN clinical_JJ symptoms_NNS and_CC with_IN a_DT history_NN of_IN diabetes_NN mellitus_NN ._SENT Patient_JJ selection_NN and_CC sample_NN collection_NN ._SENT |_SYM All_DT patient-related_JJ procedures_NNS used_VBN in_IN this_DT study_NN conformed_VBN to_TO protocols_NNS approved_VBN by_IN the_DT Institutional_NP Review_NP Board_NP of_IN the_DT University_NP of_IN Connecticut_NP Health_NP Center_NP ._SENT The_DT purpose_NN and_CC scope_NN of_IN the_DT study_NN were_VBD explained_VBN to_TO patients_NNS presenting_VBG for_IN endodontic_JJ treatment_NN for_IN a_DT tooth_NN with_IN pulp_NN necrosis_NN and_CC apical_JJ periodontitis_NN ._SENT Patients_NNS who_WP consented_VBD to_TO participate_VB in_IN the_DT study_NN and_CC who_WP had_VBD not_RB been_VBN treated_VBN with_IN antibiotics_NNS in_IN the_DT preceding_JJ 3_CD months_NNS were_VBD included_VBN in_IN the_DT study_NN ._SENT Patients_NNS who_WP indicated_VBD that_IN they_PP had_VBD diabetes_NN mellitus_NN received_VBD a_DT free_JJ HbA1c_NP test_NN to_TO determine_VB the_DT degree_NN of_IN their_PP$ glycemic_JJ control_NN ._SENT Patients_NNS who_WP had_VBD no_DT history_NN of_IN diabetes_NN were_VBD offered_VBN a_DT free_JJ fasting_VBG blood_NN glucose_NN test_NN to_TO verify_VB that_IN they_PP did_VBD not_RB have_VB diabetes_NN ._SENT The_DT teeth_NNS involved_VBD had_VBD a_DT negative_JJ pulp_NN test_NN result_NN ,_, had_VBD a_DT periapical_JJ radiolucency_NN on_IN a_DT preoperative_JJ radiograph_NN ,_, and_CC had_VBD not_RB had_VBN any_DT previous_JJ endodontic_JJ procedures_NNS ._SENT Detailed_JJ information_NN regarding_VBG signs_NNS and_CC symptoms_NNS and_CC radiographic_JJ and_CC clinical_JJ data_NNS were_VBD collected_VBN ._SENT Symptomatic_JJ patients_NNS were_VBD defined_VBN as_IN patients_NNS who_WP had_VBD a_DT preoperative_JJ visual_JJ analogue_NN score_NN of_IN 30_CD or_CC more_JJR on_IN a_DT 100-point_JJ scale_NN ,_, had_VBD moderate_JJ to_TO severe_JJ pain_NN to_TO percussion_NN or_CC palpation_NN of_IN the_DT tooth_NN involved_VBN ,_, and/or_CC had_VBD swelling_VBG ._SENT The_DT technique_NN for_IN sample_NN collection_NN was_VBD as_RB follows_VBZ :_: following_VBG isolation_NN of_IN the_DT tooth_NN involved_VBN with_IN a_DT rubber_NN dam_NN ,_, the_DT field_NN was_VBD disinfected_VBN with_IN 30_CD %_NN H2O2_NP and_CC then_RB 5_CD %_NN tincture_NN of_IN iodine_NN ._SENT Caries_NN and/or_CC existing_JJ restorations_NNS ,_, if_IN present_JJ ,_, were_VBD removed_VBN ,_, and_CC then_RB the_DT cavity_NN was_VBD wiped_VBN with_IN a_DT sterile_JJ cotton_NN pellet_NN slightly_RB wet_JJ with_IN 1_CD %_NN buffered_VBN NaOCl_NP ,_, with_IN care_NN that_IN it_PP did_VBD not_RB seep_VB into_IN the_DT canal_NN ._SENT The_DT halogen_NN disinfectants_NNS were_VBD then_RB inactivated_VBN with_IN 5_CD %_NN sodium_NN thiosulfate_NNS ._SENT The_DT pulp_NN chamber_NN was_VBD then_RB accessed_VBN with_IN a_DT new_JJ sterile_JJ bur_NN ._SENT If_IN purulence_NN or_CC serous_JJ fluid_NN was_VBD present_JJ in_IN the_DT canal_NN ,_, this_DT was_VBD directly_RB sampled_VBN with_IN three_CD size_NN fine_JJ paper_NN points_NNS ._SENT Otherwise_RB ,_, sterile_JJ saline_NN was_VBD deposited_VBN in_IN the_DT canal_NN ,_, making_VBG sure_JJ that_IN it_PP did_VBD not_RB overflow_VB ._SENT A_DT size_NN 15_CD to_TO 30_CD file_NN (_( depending_VBG on_IN the_DT canal_NN size_NN )_) was_VBD used_VBN to_TO negotiate_VB the_DT canal_NN to_TO the_DT estimated_JJ length_NN ._SENT If_IN the_DT canal_NN was_VBD very_RB calcified_VBN ,_, Gates_NP Glidden_NP burs_VBZ sizes_NNS 2_CD and_CC 3_CD were_VBD used_VBN so_RB that_IN the_DT paper_NN point_NN could_MD penetrate_VB to_TO a_DT depth_NN close_NN to_TO the_DT estimated_JJ canal_NN length_NN ._SENT Three_CD fine_JJ paper_NN points_NNS were_VBD then_RB used_VBN to_TO obtain_VB the_DT sample_NN ._SENT The_DT last_JJ paper_NN point_NN was_VBD left_VBN in_IN the_DT canal_NN for_IN 30_CD s._NN In_IN multicanaled_JJ teeth_NNS ,_, one_CD paper_NN point_NN sample_NN was_VBD obtained_VBN from_IN each_DT canal_NN unless_IN the_DT canals_NNS were_VBD very_RB calcified_VBN ,_, in_IN which_WDT case_NN sampling_NN of_IN the_DT canal_NN in_IN the_DT root_NN with_IN the_DT largest_JJS periapical_JJ lesion_NN and_CC the_DT largest_JJS canal_NN was_VBD done_VBN ._SENT The_DT paper_NN points_NNS were_VBD placed_VBN in_IN sterile_JJ ,_, DNA-_NP and_CC RNA-free_NP vials_NNS containing_VBG 1_CD ml_NN of_IN filter-sterilized_JJ 10_CD mM_NP Tris-HCl_NP ,_, 1_CD mM_NP EDTA_NP (_( pH_NN 8_CD )_) ,_, and_CC 0.5_CD g_NN of_IN sterile_JJ glass_NN beads_NNS (_( diameter_NN ,_, 0.71_CD to_TO 1.18_CD mm_NN )_) ._SENT The_DT vials_NNS were_VBD frozen_VBN at_IN -70C_NN until_IN used_VBN ._SENT DNA_NP extraction_NN ._SENT |_SYM The_DT vials_NNS with_IN paper_NN point_NN specimens_NNS were_VBD vortexed_VBN for_IN 2_CD min_NN to_TO disperse_VB microbial_JJ cellular_JJ material_NN into_IN suspension_NN ._SENT The_DT suspension_NN was_VBD removed_VBN from_IN the_DT original_JJ vial_NN and_CC transferred_VBN to_TO 2-ml_JJ sterile_JJ vials_NNS ,_, which_WDT were_VBD then_RB centrifuged_VBN at_IN 7,500_CD rpm_NN (_( all_DT centrifuge_NN procedures_NNS were_VBD carried_VBN out_RP with_IN Eppendorf_NP [_SYM Westbury_NP ,_, N.Y._NP ]_SYM scientific_JJ microcentrifuge_NN model_NN 5417C_NN )_) for_IN 10_CD min_NN ,_, and_CC the_DT supernatant_JJ was_VBD again_RB removed_VBN ._SENT DNAs_NNS were_VBD extracted_VBN from_IN the_DT cellular_JJ pellet_NN by_IN one_CD of_IN two_CD methods_NNS ._SENT The_DT first_JJ method_NN (_( specimens_NNS 1_CD to_TO 10_CD )_) used_VBD the_DT Chelex_NP extraction_NN and_CC boiling_VBG technique_NN ._SENT Briefly_RB ,_, this_DT method_NN involved_VBD the_DT addition_NN of_IN 75_CD mul_NN of_IN 15_CD %_NN Chelex_NP 100_CD resin_NN (_( Bio-Rad_NP )_) to_TO the_DT pellet_NN resuspended_VBN in_IN 0.5_CD ml_NN of_IN Tris-HCl_NP buffer_NN and_CC thorough_JJ mixing_VBG ,_, followed_VBN by_IN incubation_NN at_IN 56C_NN for_IN 30_CD min_NN in_IN a_DT dry_JJ heat_NN block_NN ._SENT The_DT mixture_NN was_VBD boiled_VBN in_IN a_DT dry_JJ heat_NN block_NN for_IN 10_CD min_NN and_CC then_RB chilled_VBN on_IN ice_NN for_IN 5_CD min_NN ._SENT It_PP was_VBD then_RB centrifuged_VBN at_IN 12,000_CD rpm_NN for_IN 2_CD to_TO 3_CD min_NN ._SENT The_DT supernatant_JJ was_VBD carefully_RB removed_VBN ,_, with_IN the_DT Chelex_NN being_VBG avoided_VBN ._SENT The_DT DNA_NN was_VBD stored_VBN at_IN -20C_NN until_IN it_PP was_VBD ready_JJ for_IN use_NN in_IN the_DT PCR_NP ._SENT For_IN the_DT last_JJ 14_CD specimens_NNS ,_, we_PP switched_VBD to_TO the_DT enzymatic_JJ extraction_NN method_NN ,_, according_VBG to_TO the_DT protocol_NN described_VBN for_IN the_DT QIAamp_NP DNA_NP mini_JJ kit_NN (_( Qiagen_NP ,_, Valencia_NP ,_, Calif._NP )_) ,_, because_IN of_IN the_DT manufacturer_NN 's_POS claims_NNS of_IN improved_VBN purity_NN and_CC yield_NN of_IN the_DT extracted_VBN DNA_NN and_CC because_IN it_PP allows_VBZ the_DT extraction_NN of_IN fungal_JJ DNA_NN for_IN use_NN in_IN future_JJ research_NN ._SENT The_DT pellet_NN was_VBD suspended_VBN in_IN 180_CD mul_NN of_IN enzyme_NN solution_NN (_( 20_CD mg_NN of_IN lysozyme_NN per_IN ml_NN ,_, 20_CD mM_NP Tris_NP HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 2_CD mM_NP EDTA_NP ,_, 1.2_CD %_NN Triton_NP )_) and_CC incubated_VBN for_IN 30_CD min_NN at_IN 37C_JJ ._SENT Proteinase_NN K_NN (_( 20_CD mul_NN )_) and_CC RNase_NP A_NP (_( 4_CD mul_NN at_IN 100_CD mg/ml_NN )_) were_VBD added_VBN ,_, and_CC the_DT specimen_NN was_VBD incubated_VBN for_IN 2_CD min_NN at_IN room_NN temperature_NN ._SENT Buffer_NN AL_NNS (_( 200_CD mul_NN )_) was_VBD added_VBN ,_, and_CC the_DT specimen_NN was_VBD vortexed_VBN and_CC incubated_VBN at_IN 56C_NN for_IN 30_CD min_NN and_CC then_RB for_IN 15_CD min_NN at_IN 95C_NN ._SENT Ethanol_NN (_( 200_CD mul_NN at_IN 96_CD to_TO 100_CD %_NN )_) was_VBD added_VBN ,_, followed_VBN by_IN vortexing_NN and_CC brief_JJ centrifugation_NN ._SENT The_DT mixture_NN was_VBD then_RB added_VBN to_TO a_DT QIAamp_JJ spin_NN column_NN and_CC centrifuged_VBN at_IN 8,000_CD rpm_NN for_IN 1_CD min_NN ._SENT The_DT column_NN was_VBD then_RB placed_VBN in_IN a_DT clean_JJ 2-ml_JJ collection_NN tube_NN ,_, 500_CD mul_NN of_IN buffer_NN AW1_NP was_VBD added_VBN ,_, and_CC the_DT mixture_NN was_VBD centrifuged_VBN at_IN 8,000_CD rpm_NN for_IN 1_CD min_NN ._SENT The_DT column_NN was_VBD again_RB placed_VBN in_IN a_DT clean_JJ 2-ml_JJ collection_NN tube_NN ,_, and_CC 500_CD mul_NN of_IN buffer_NN AW2_NP was_VBD added_VBN ,_, followed_VBN by_IN centrifugation_NN at_IN 14,000_CD rpm_NN for_IN 3_CD min_NN ._SENT Then_RB ,_, buffer_NN AE_NP (_( 200_CD mul_NN )_) was_VBD added_VBN ,_, followed_VBN by_IN centrifugation_NN at_IN 8,000_CD rpm_NN for_IN 1_CD min_NN ._SENT The_DT elutions_NNS were_VBD combined_VBN for_IN a_DT total_JJ yield_NN of_IN 400_CD mul_NN ,_, which_WDT was_VBD aliquoted_VBN in_IN sterile_JJ ,_, DNA-_NP and_CC RNA-free_NP conical_JJ tubes_NNS and_CC frozen_VBN at_IN -20C_NN until_IN use_NN ._SENT Prior_RB to_TO performing_VBG the_DT second_JJ extraction_NN method_NN we_PP conducted_VBD a_DT pilot_NN experiment_NN to_TO determine_VB if_IN the_DT two_CD different_JJ extraction_NN methods_NNS affected_VBD the_DT yield_NN of_IN extracted_VBN DNA_NN from_IN representative_JJ stock_NN strains_NNS of_IN two_CD gram-positive_JJ bacteria_NNS and_CC two_CD gram-negative_JJ bacteria_NNS ._SENT This_DT experiment_NN was_VBD also_RB run_VBN with_IN one_CD clinical_JJ sample_NN that_WDT was_VBD divided_VBN into_IN two_CD aliquots_NNS ,_, and_CC each_DT aliquot_NN was_VBD extracted_VBN by_IN one_CD of_IN the_DT two_CD methods_NNS ._SENT PCR_NP was_VBD later_RBR run_VBN with_IN primers_NNS specific_JJ for_IN all_PDT the_DT bacteria_NNS under_IN study_NN ._SENT These_DT experiments_NNS did_VBD not_RB reveal_VB any_DT perceptible_JJ differences_NNS in_IN DNA_NN yields_NNS or_CC PCR_NP results_NNS between_IN the_DT different_JJ extraction_NN methods_NNS ,_, and_CC therefore_RB ,_, the_DT results_NNS obtained_VBN by_IN both_DT methods_NNS are_VBP considered_VBN together_RB ._SENT The_DT yield_NN of_IN extracted_VBN DNA_NN was_VBD quantified_VBN for_IN each_DT of_IN the_DT control_NN stock_NN bacterial_JJ strains_NNS and_CC clinical_JJ specimens_NNS by_IN using_VBG a_DT Hoefer_NP DyNA200_NP fluorometer_NN (_( Amersham_NP Pharmacia_NP Biotech_NP ,_, Piscataway_NP ,_, N.J._NP )_) ._SENT The_DT yield_NN ranged_VBD from_IN 2_CD to_TO 33_CD ng/mul_NNS for_IN the_DT stock_NN bacterial_JJ strains_NNS and_CC 1_CD to_TO 19.5_CD ng/mul_NNS for_IN the_DT clinical_JJ specimens_NNS ._SENT Microorganism_NN selection_NN ._SENT |_SYM We_PP chose_VBD to_TO evaluate_VB the_DT root_NN canals_NNS for_IN the_DT presence_NN of_IN 10_CD microorganisms_NNS that_WDT have_VBP frequently_RB been_VBN isolated_VBN from_IN root_NN canals_NNS with_IN necrotic_JJ pulp_NN ._SENT Our_PP$ selection_NN of_IN the_DT bacteria_NNS was_VBD based_VBN on_IN the_DT following_VBG criteria_NNS :_: organisms_NNS that_WDT are_VBP highly_RB prevalent_JJ in_IN root_NN canals_NNS with_IN necrotic_JJ pulp_NN (_( black-pigmented_JJ bacteria_NNS ,_, Fusobacterium_NP nucleatum_NP ,_, Peptostreptococcus_NP micros_NNS ,_, and_CC Streptococcus_NP spp._NP )_) ,_, organisms_NNS that_WDT are_VBP frequently_RB found_VBN in_IN patients_NNS with_IN symptomatic_JJ endodontic_JJ infections_NNS (_( P._NP intermedia_NP ,_, P._NP nigrescens_NP ,_, Porphyromonas_NP gingivalis_NP ,_, and_CC Porphyromonas_NP endodontalis_NP )_) ,_, organisms_NNS that_WDT have_VBP been_VBN detected_VBN in_IN root_NN canals_NNS from_IN patients_NNS who_WP have_VBP failed_VBN endodontic_JJ treatment_NN (_( Enterococcus_NP spp._NP )_) ,_, and_CC organisms_NNS that_WDT are_VBP prevalent_JJ in_IN patients_NNS with_IN severe_JJ periodontitis_NN and_CC that_WDT have_VBP recently_RB been_VBN identified_VBN in_IN root_NN canals_NNS by_IN PCR_NP (_( T._NP denticola_NP and_CC B._NP forsythus_NN )_) ._SENT PCR_NP amplification_NN of_IN rDNA_NN ._SENT |_SYM Previously_RB published_VBN primer_NN pairs_NNS were_VBD selected_VBN for_IN specific_JJ PCR_NP amplification_NN of_IN 16S_JJ rDNAs_NNS (_( or_CC the_DT tuf_NN gene_NN for_IN the_DT genus_NN Enterococcus_NN )_) of_IN the_DT microorganisms_NNS listed_VBN in_IN Table_NP ._SENT Initially_RB ,_, a_DT universal_JJ eubacterial_JJ primer_NN pair_NN was_VBD used_VBN to_TO detect_VB DNAs_NP from_IN all_DT bacterial_JJ species_NNS present_JJ in_IN the_DT sample_NN ._SENT Subsequently_RB ,_, a_DT PCR_NP mixture_NN with_IN oligonucleotide_NN primers_NNS specific_JJ for_IN rDNAs_NNS was_VBD used_VBN ._SENT At_IN least_JJS duplicate_JJ experiments_NNS were_VBD run_VBN for_IN each_DT specimen_NN ._SENT PCR_NP amplification_NN was_VBD performed_VBN in_IN a_DT thermal_JJ cycler_NN (_( PE9700_NP or_CC PE2400_NP ;_: Perkin-Elmer_NP Applied_NP Biosystems_NP ,_, Foster_NP City_NP ,_, Calif._NP )_) ._SENT It_PP was_VBD carried_VBN out_RP in_IN a_DT volume_NN of_IN 50_CD mul_NN containing_VBG 10_CD mul_NN of_IN extracted_VBN sample_NN DNA_NN or_CC 5_CD mul_NN of_IN extracted_VBN control_NN stock_NN bacterial_JJ DNA_NN (_( see_VB below_IN )_) ,_, 5_CD mul_NN of_IN 10x_NP PCR_NP buffer_NN ,_, 0.25_CD mul_NN of_IN 5_CD U_NN of_IN Taq_NP DNA_NP polymerase_NN (_( Eppendorf_NP ,_, Cologne_NP ,_, Germany_NP )_) per_IN mul_NN or_CC 0.5_CD mul_NN of_IN HotStar_NP Taq_NP (_( Qiagen_NP )_) ,_, 1.5_CD mM_NP MgCl2_NP ,_, 0.2_CD mM_NP concentrations_NNS of_IN each_DT of_IN the_DT four_CD deoxynucleoside_NN triphosphates_NNS (_( Takara_NP ,_, Otsu_NP ,_, Shiga_NP ,_, Japan_NP )_) ,_, and_CC a_DT 0.5_CD muM_NN concentration_NN (_( 500_CD ng_NNS )_) of_IN each_DT (_( sense_NN and_CC antisense_NN )_) primer_NN ;_: the_DT balance_NN consisted_VBN of_IN sterile_JJ ultrapure_NN water_NN ._SENT PCR_NP conditions_NNS for_IN each_DT primer_NN combination_NN were_VBD optimized_VBN in_IN pilot_NN experiments_NNS ._SENT The_DT PCR_NP conditions_NNS used_VBN were_VBD generally_RB as_RB follows_VBZ :_: the_DT initial_JJ denaturation_NN was_VBD at_IN 94C_NN for_IN 2_CD min_NN for_IN Eppendorf_NP Taq_NP or_CC 15_CD min_NN for_IN HotStar_NP Taq_NP ._SENT This_DT was_VBD followed_VBN by_IN 30_CD cycles_NNS of_IN denaturation_NN at_IN 94C_NN for_IN 15_CD s_NNS ,_, annealing_VBG at_IN a_DT temperature_NN that_WDT depended_VBD on_IN the_DT primer_NN for_IN 15_CD s_NNS ,_, and_CC extension_NN at_IN 72C_NP for_IN 45_CD s._NN The_DT final_JJ extension_NN was_VBD at_IN 72C_NP for_IN 5_CD min_NN ,_, and_CC then_RB the_DT products_NNS were_VBD cooled_VBN to_TO 4C_JJ until_IN they_PP were_VBD removed_VBN ._SENT The_DT amplification_NN products_NNS were_VBD analyzed_VBN by_IN 2_CD %_NN agarose_NN gel_NN electrophoresis_NN in_IN TAE_NP buffer_NN (_( 40_CD mM_NP Tris-acetate_NP ,_, 2_CD mM_NP EDTA_NP [_SYM pH_NN 8.3_CD ]_SYM )_) ._SENT The_DT Power_NP Pac_NP 1000_CD apparatus_NN (_( Bio-Rad_NP ,_, Hercules_NP ,_, Calif._NP )_) was_VBD set_VBN at_IN 110_CD mA_NNS for_IN 2_CD h_NN or_CC 95_CD V_CD for_IN 1_CD h._NN The_DT gels_NNS were_VBD stained_VBN with_IN 0.5_CD mug_NN of_IN ethidium_NN bromide_NN per_IN ml_NN for_IN 30_CD min_NN and_CC destained_JJ with_IN water_NN for_IN 20_CD min_NN ._SENT The_DT PCR_NP products_NNS were_VBD visualized_VBN under_IN UV_NP light_NN with_IN an_DT Alpha_NP Imager_NP (_( Alpha_NP Innotech_NP Corp._NP ,_, San_NP Leandro_NP ,_, Calif._NP )_) ._SENT For_IN each_DT primer_NN we_PP ran_VBD a_DT number_NN of_IN PCR_NP controls_NNS ._SENT These_DT included_VBD the_DT use_NN of_IN DNA_NP from_IN American_NP Type_NP Culture_NP Collection_NP (_( ATCC_NP )_) stock_NN strains_NNS of_IN the_DT respective_JJ bacterial_JJ species_NNS (_( Enterococcus_NP faecalis_NP for_IN the_DT Enterococcus_NP primers_NNS )_) as_IN positive_JJ controls_NNS ._SENT The_DT Streptococcus-specific_NP primers_NNS were_VBD reported_VBN as_IN being_VBG specific_JJ for_IN Streptococcus_NP intermedius_NP ,_, with_IN possible_JJ cross-reactivity_NN with_IN Streptococcus_NP milleri_NP isolates_VBZ ._SENT However_RB ,_, our_PP$ positive_JJ control_NN experiments_NNS have_VBP shown_VBN that_IN these_DT primers_NNS reacted_VBN with_IN S._NP intermedius_NP ,_, Streptococcus_NP constellatus_NN ,_, Streptococcus_NP anginosus_NP ,_, Streptococcus_NP mutans_NNS ,_, Streptococcus_NP sanguis_NNS ,_, and_CC Streptococcus_NP bovis_NP ,_, all_DT at_IN a_DT single_JJ band_NN at_IN 500_CD bp_NN ._SENT Thus_RB ,_, these_DT primers_NNS were_VBD considered_VBN Streptococcus_NP genus_NN specific_NN ._SENT The_DT DNAs_NP of_IN the_DT ATCC_NP stock_NN strains_NNS were_VBD extracted_VBN from_IN spectrophotometrically_RB determined_VBN concentrations_NNS of_IN 3_CD x_SYM 108_CD bacterial_JJ cells/ml_NN that_WDT were_VBD cultured_VBN under_IN ideal_JJ conditions_NNS for_IN the_DT particular_JJ species_NN ._SENT An_DT additional_JJ positive_JJ control_NN was_VBD the_DT universal_JJ primer_NN pair_NN specific_JJ for_IN bacterial_JJ 16S_JJ rDNA_NN ,_, with_IN which_WDT positive_JJ results_NNS were_VBD obtained_VBN with_IN DNA_NN from_IN all_DT bacteria_NNS but_CC negative_JJ results_NNS were_VBD obtained_VBN with_IN DNA_NP from_IN Candida_NP albicans_NNS ._SENT In_IN addition_NN ,_, each_DT primer_NN set_NN was_VBD run_VBN with_IN DNA_NN extracted_VBN from_IN all_DT other_JJ bacterial_JJ species_NNS used_VBN in_IN the_DT study_NN together_RB with_IN DNA_NN extracted_VBN from_IN ATCC_NP stock_NN strains_NNS of_IN Eubacterium_NP nodatum_NP and_CC Actinomyces_NP israelii_NP and_CC with_IN water_NN (_( no_DT DNA_NN )_) as_IN negative_JJ controls_NNS ._SENT Representative_NP PCR_NP products_NNS obtained_VBN by_IN use_NN of_IN each_DT of_IN the_DT species-_NN or_CC genus-specific_JJ primers_NNS with_IN patient_JJ specimens_NNS were_VBD directly_RB sequenced_JJ (_( see_VB "_`` Cloning_VBG and_CC sequencing_VBG of_IN novel_JJ 16S_JJ rDNA_NN sequences_NNS "_'' below_IN )_) to_TO determine_VB the_DT published_JJ sequence_NN closest_JJS to_TO that_DT of_IN the_DT organism_NN amplified_VBD ._SENT Cloning_VBG and_CC sequencing_VBG of_IN novel_JJ 16S_JJ rDNA_NN sequences_NNS ._SENT |_SYM Two_NP specimens_NNS ,_, specimens_NNS SP05_NP and_CC SP08_NP ,_, yielded_VBD a_DT PCR_NP product_NN with_IN the_DT universal_JJ primer_NN pair_NN but_CC no_DT product_NN with_IN the_DT 10_CD specific_JJ primers_NNS tested_VBD ._SENT Specimen_NN SP08_NP yielded_VBD too_RB little_JJ product_NN for_IN cloning_VBG and_CC will_MD not_RB be_VB described_VBN further_RBR ._SENT Amplification_NN products_NNS from_IN specimen_NN SP05_NP were_VBD cloned_VBN into_IN the_DT vector_NN pCR_NN 2.1-TOPO_NP TA_NP (_( Invitrogen_NP ,_, Carlsbad_NP ,_, Calif._NP )_) according_VBG to_TO the_DT instructions_NNS of_IN the_DT manufacturer_NN or_CC were_VBD sequenced_VBN directly_RB ._SENT For_IN cloning_VBG ,_, the_DT PCR_NP product_NN was_VBD transformed_VBN into_IN Escherichia_NP coli_NNS One-Shot_NP TOP10_NP ._SENT Colonies_NNS containing_VBG the_DT insert_NN were_VBD used_VBN to_TO inoculate_VB Luria-Bertani_NP agar_NN (_( Miller_NP ;_: Fisher_NP Scientific_NP Co._NP ,_, Pittsburgh_NP ,_, Pa._NP )_) ._SENT Plasmid_NP DNA_NP was_VBD purified_VBN with_IN the_DT QIAprep_NP Spin_NP Miniprep_NP kit_NN (_( Qiagen_NP )_) or_CC the_DT Concert_NP Rapid_NP Plasmid_NP purification_NN kit_NN (_( Life_NP Technologies_NP ,_, Gibco_NP BRL_NP ,_, Rockville_NP ,_, Md._NP )_) ._SENT The_DT purified_VBN plasmid_NN DNA_NN from_IN the_DT cloning_VBG procedure_NN was_VBD sequenced_VBN in_IN the_DT University_NP of_IN Connecticut_NP Health_NP Center_NP Molecular_NP Core_NP Facility_NP by_IN using_VBG an_DT ABI_NP Prism_NN 3100_CD genetic_JJ analyzer_NN (_( Perkin-Elmer_NP Applied_NP Biosystems_NP )_) and_CC reverse_VB primer_JJR M13_NN or_CC T7_JJ (_( Invitrogen_NP )_) ._SENT The_DT universal_JJ PCR_NP products_NNS were_VBD purified_VBN with_IN the_DT Concert_NP Rapid_NP PCR_NP purification_NN system_NN (_( Life_NP Technologies_NP ,_, Gibco_NP BRL_NP )_) and_CC directly_RB sequenced_JJ by_IN using_VBG the_DT universal_JJ forward_JJ and_CC reverse_JJ primers_NNS ._SENT The_DT resulting_VBG sequences_NNS were_VBD used_VBN to_TO search_VB databases_NNS available_JJ through_IN the_DT National_NP Center_NP for_IN Biotechnology_NP Information_NP ._SENT PCR_NP products_NNS obtained_VBN with_IN specific_JJ primers_NNS from_IN representative_JJ patient_NN specimens_NNS were_VBD partially_RB sequenced_VBN directly_RB after_IN purification_NN as_RB described_VBD above_RB to_TO verify_VB the_DT identity_NN of_IN the_DT product_NN ._SENT All_DT species-specific_JJ primers_NNS yielded_VBD sequences_NNS that_WDT matched_VBD published_JJ sequences_NNS for_IN the_DT respective_JJ species_NN ._SENT The_DT two_CD representative_JJ products_NNS for_IN the_DT genus-specific_JJ primers_NNS yielded_VBD sequences_NNS that_WDT had_VBD close_JJ homology_NN with_IN the_DT sequences_NNS of_IN S._NP sanguis_NP ,_, unidentified_JJ oral_JJ streptococci_NNS (_( GenBank_NP accession_NN no_RB ._SENT )_) ,_, Streptococcus_NP cristatus_NN ,_, and_CC Streptococcus_NP pneumoniae_NNS for_IN the_DT Streptococcus_NP genus-specific_JJ primers_NNS and_CC various_JJ Enterococcus_NP spp._NN for_IN the_DT Enterococcus_NP genus-specific_JJ primers_NNS ._SENT Phylogenetic_JJ analyses_NNS of_IN the_DT novel_JJ 16S_JJ rDNA_NN sequence_NN ._SENT |_SYM Significant_JJ database_NN hits_NNS were_VBD aligned_VBN with_IN our_PP$ unknown_JJ sequence_NN by_IN using_VBG ClustalW_JJ software_NN in_IN MacVector_NP (_( Genetics_NP Computer_NP Group_NP ,_, Oxford_NP Molecular_NP Co._NP )_) ._SENT A_DT neighbor-joining_JJ phylogenetic_JJ tree_NN was_VBD constructed_VBN from_IN the_DT alignment_NN by_IN using_VBG MacVector_NP (_( Genetics_NP Computer_NP Group_NP ,_, Oxford_NP Molecular_NP Co._NP )_) ._SENT A_DT distance_NN matrix_NN was_VBD constructed_VBN by_IN using_VBG a_DT Tamura-Nei_NP model_NN without_IN gamma_NN correction_NN and_CC with_IN gaps_NNS distributed_VBN proportionately_RB ._SENT Neighbor-joining_VBG bootstrap_NN values_NNS were_VBD derived_VBN from_IN 1,000_CD replications_NNS and_CC were_VBD added_VBN to_TO the_DT tree_NN ._SENT Data_NP analysis_NN ._SENT |_SYM The_DT associations_NNS between_IN the_DT positive_JJ identification_NN of_IN a_DT bacterial_JJ species_NN or_CC genus_NN and_CC symptoms_NNS or_CC a_DT history_NN of_IN diabetes_NN were_VBD analyzed_VBN by_IN odds_NNS ratio_NN (_( OR_JJ )_) analysis_NN ._SENT OR_CC associations_NNS of_IN 2_CD or_CC more_JJR were_VBD considered_VBN positive_JJ associations_NNS ._SENT These_DT positive_JJ associations_NNS were_VBD further_RBR analyzed_VBN by_IN a_DT chi-square_NN analysis_NN to_TO determine_VB their_PP$ statistical_JJ significance_NN ._SENT Nucleotide_NN sequence_NN accession_NN number_NN ._SENT |_SYM The_DT sequence_NN that_WDT forms_VBZ a_DT basal_JJ lineage_NN in_IN the_DT Olsenella_NP clade_NN detected_VBD in_IN this_DT study_NN has_VBZ been_VBN deposited_VBN in_IN GenBank_NP under_IN accession_NN number_NN ._SENT TABLE_NN 1_CD |_SYM Oligonucleotide_NN primers_NNS used_VBN Of_IN 24_CD patients_NNS participating_VBG in_IN the_DT study_NN ,_, 8_CD were_VBD considered_VBN to_TO be_VB symptomatic_JJ and_CC 6_CD had_VBD a_DT history_NN of_IN diabetes_NN mellitus_NNS (_( 2_CD with_IN type_NN 1_CD diabetes_NN mellitus_NN and_CC 4_CD with_IN type_NN 2_CD diabetes_NN mellitus_NN )_) ._SENT The_DT HbA1c_NP results_NNS revealed_VBD that_IN three_CD diabetic_JJ patients_NNS had_VBD moderate_JJ glycemic_JJ control_NN (_( 7_CD to_TO 10_CD %_NN )_) and_CC three_CD had_VBD poor_JJ glycemic_JJ control_NN (_( >10_JJ %_NN )_) ._SENT Of_IN the_DT 18_CD nondiabetic_JJ patients_NNS ,_, 9_CD agreed_VBD to_TO take_VB the_DT fasting_VBG blood_NN glucose_NN test_NN ,_, and_CC all_RB had_VBD results_NNS below_IN 126_CD mg/dl_NN ,_, which_WDT is_VBZ generally_RB accepted_VBN as_IN the_DT threshold_NN value_NN for_IN the_DT diagnosis_NN of_IN diabetes_NN mellitus_NN ._SENT Twenty-two_NN of_IN the_DT 24_CD specimens_NNS tested_VBN reacted_VBD positively_RB with_IN the_DT universal_JJ bacterial_JJ primer_NN pair_NN ._SENT Two_CD specimens_NNS ,_, specimen_NN SP09_NP (_( from_IN a_DT nondiabetic_JJ individual_NN )_) and_CC specimen_NN SP12_NN (_( from_IN an_DT individual_NN with_IN type_NN 2_CD diabetes_NN )_) ,_, had_VBD no_DT identifiable_JJ PCR_NP amplicons_NNS with_IN the_DT universal_JJ primers_NNS ._SENT Retrospective_JJ analysis_NN of_IN the_DT clinical_JJ conditions_NNS of_IN the_DT root_NN canals_NNS from_IN which_WDT these_DT two_CD specimens_NNS were_VBD sampled_VBN revealed_VBD that_IN the_DT root_NN canals_NNS may_MD not_RB have_VB had_VBN bacterial_JJ contamination_NN at_IN the_DT time_NN that_IN treatment_NN was_VBD initiated_VBN (_( see_VB Discussion_NP )_) ._SENT Of_IN the_DT 22_CD specimens_NNS positive_JJ for_IN bacteria_NNS by_IN PCR_NP ,_, 20_CD yielded_VBD amplicons_NNS with_IN 1_CD or_CC more_JJR of_IN the_DT 10_CD specific_JJ primer_NN pairs_NNS ._SENT Two_CD specimens_NNS (_( specimens_NNS SP05_NP and_CC SP08_NP )_) were_VBD positive_JJ for_IN bacteria_NNS by_IN PCR_NP with_IN the_DT universal_JJ primer_NN pair_NN but_CC did_VBD not_RB have_VB a_DT positive_JJ reaction_NN with_IN any_DT of_IN the_DT specific_JJ primers_NNS used_VBD ._SENT Certain_JJ organisms_NNS such_JJ as_IN F._NP nucleatum_NP ,_, P._NP micros_NP ,_, Streptococcus_NP spp._NP ,_, and_CC P._NP nigrescens_NNS were_VBD more_JJR commonly_RB identified_VBN than_IN other_JJ organisms_NNS ._SENT The_DT results_NNS of_IN an_DT analysis_NN that_WDT used_VBD the_DT OR_NN of_IN the_DT association_NN between_IN specific_JJ organisms_NNS and_CC the_DT presence_NN of_IN symptoms_NNS are_VBP shown_VBN in_IN Table_NP ._SENT Streptococcus_NN spp._NN ,_, F._NP nucleatum_NN ,_, and_CC P._NP gingivalis_NNS were_VBD associated_VBN with_IN symptoms_NNS ._SENT Further_JJR analysis_NN by_IN a_DT chi-square_NN test_NN revealed_VBD that_IN there_EX was_VBD a_DT statistically_RB significant_JJ association_NN between_IN Streptococcus_NP spp._NP and_CC symptoms_NNS (_( P_NN <_0.001) 0.05_CD by_IN chi-square_NN analysis_NN )_) ._SENT Six_CD patients_NNS in_IN this_DT study_NN had_VBD a_DT history_NN of_IN type_NN 1_CD or_CC type_VB 2_CD diabetes_NN mellitus_NN ,_, with_IN various_JJ degrees_NNS of_IN glycemic_JJ control_NN ._SENT An_DT analysis_NN of_IN the_DT association_NN of_IN diabetes_NN with_IN specific_JJ root_NN canal_NN microorganisms_NNS was_VBD performed_VBN ._SENT That_DT analysis_NN revealed_VBD a_DT positive_JJ association_NN between_IN diabetes_NN and_CC P._NP endodontalis_NP and_CC P._NP gingivalis_NNS ;_: however_RB ,_, these_DT associations_NNS were_VBD not_RB statistically_RB significant_JJ (_( P_NN >_SYM 0.05_CD by_IN chi-square_NN analysis_NN )_) ._SENT Other_JJ patterns_NNS related_VBN to_TO the_DT type_NN of_IN diabetes_NN or_CC degree_NN of_IN glycemic_JJ control_NN could_MD not_RB be_VB established_VBN ._SENT The_DT association_NN between_IN symptoms_NNS or_CC diabetes_NN and_CC the_DT number_NN of_IN different_JJ organisms_NNS identified_VBN in_IN the_DT specimens_NNS that_WDT were_VBD positive_JJ with_IN the_DT universal_JJ primers_NNS was_VBD analyzed_VBN ._SENT The_DT mean_JJ number_NN of_IN organisms_NNS identified_VBN in_IN the_DT 8_CD symptomatic_JJ patients_NNS was_VBD 3_CD +-_NN 1.4_CD ,_, whereas_IN the_DT mean_JJ number_NN was_VBD 2.78_CD +-_NN 1.85_CD for_IN the_DT 14_CD patients_NNS with_IN mild_JJ or_CC no_DT symptoms_NNS ._SENT The_DT mean_JJ number_NN of_IN organisms_NNS identified_VBN in_IN the_DT five_CD patients_NNS with_IN diabetes_NN (_( after_IN excluding_VBG specimen_NN SP12_NP ,_, which_WDT was_VBD negative_JJ with_IN the_DT universal_JJ primer_NN pair_NN )_) was_VBD 3.2_CD +-_NN 1.64_CD ,_, whereas_IN the_DT mean_JJ number_NN was_VBD 2.77_CD +-_NN 1.72_CD for_IN the_DT 17_CD nondiabetic_JJ patients_NNS ._SENT However_RB ,_, these_DT differences_NNS were_VBD not_RB statistically_RB significant_JJ (_( P_NN >_SYM 0.05_CD by_IN the_DT t_NN test_NN )_) ._SENT Direct_JJ sequencing_VBG or_CC cloning_VBG and_CC sequencing_VBG were_VBD performed_VBN with_IN the_DT PCR_NP product_NN obtained_VBN with_IN the_DT universal_JJ primer_NN pair_NN from_IN specimen_NN SP05_NP ,_, a_DT specimen_NN that_WDT did_VBD not_RB yield_VB a_DT product_NN by_IN PCR_NP with_IN any_DT of_IN the_DT specific_JJ primer_NN pairs_NNS ._SENT The_DT sequence_NN of_IN the_DT directly_RB sequenced_JJ PCR_NP product_NN and_CC the_DT sequences_NNS of_IN the_DT PCR_NP products_NNS of_IN two_CD other_JJ clones_NNS obtained_VBN with_IN the_DT TOPO_NP M13_NP reverse_JJ primer_NN were_VBD homologous_JJ ._SENT This_DT indicates_VBZ that_IN the_DT sequence_NN represents_VBZ that_IN of_IN an_DT organism_NN that_WDT is_VBZ predominant_JJ in_IN the_DT specimen_NN and_CC argues_VBZ against_IN the_DT likelihood_NN of_IN the_DT presence_NN of_IN a_DT chimeric_JJ sequence_NN ._SENT The_DT neighbor-joining_NN algorithm_NN showed_VBD that_IN this_DT sequence_NN forms_VBZ a_DT basal_JJ lineage_NN in_IN an_DT Olsenella_NP clade_NN of_IN a_DT phylogenetic_JJ tree_NN ._SENT One_CD additional_JJ clone_NN from_IN specimen_NN SP05_NP produced_VBD a_DT sequence_NN that_WDT was_VBD closest_JJS to_TO that_DT of_IN the_DT S._NP mutans_NNS ,_, Streptococcus_NP gordonii_NP ,_, and_CC S._NP sanguis_NN group_NN of_IN microorganisms_NNS ._SENT Direct_NP sequencing_NP of_IN representative_JJ PCR_NP products_NNS from_IN patient_JJ specimens_NNS with_IN each_DT of_IN the_DT specific_JJ primers_NNS produced_VBD sequences_NNS that_WDT matched_VBD those_DT from_IN corresponding_JJ species_NNS or_CC genera_NNS ._SENT FIG._NN 1_CD ._SENT |_SYM Neighbor-joining_NP tree_NN of_IN the_DT sequence_NN from_IN specimen_NN SP05_NP and_CC related_JJ 16S_JJ rDNA_NN sequences_NNS as_RB determined_VBN by_IN BLAST_NP scores_NNS ._SENT Neighbor-joining_VBG tree_NN of_IN the_DT sequence_NN from_IN specimen_NN SP05_NP and_CC related_JJ 16S_JJ rDNA_NN sequences_NNS as_RB determined_VBN by_IN BLAST_NP scores_NNS ._SENT Clade_NN associations_NNS are_VBP quantified_VBN by_IN bootstrap_NN values_NNS ._SENT From_IN left_VBN to_TO right_NN ,_, the_DT bootstrap_NN values_NNS represent_VBP node_NN support_NN from_IN neighbor_NN joining_VBG ._SENT TABLE_NN 2_CD |_SYM PCR_NP results_NNS ,_, diabetes_NN mellitus_NN type_NN ,_, HbA1c_NP results_NNS ,_, and_CC preoperative_JJ pain_NN and/or_CC swelling_VBG experience_NN (_( symptomatic_JJ )_) for_IN 24_CD patients_NNS TABLE_NP 3_CD |_SYM OR_JJ analysis_NN of_IN the_DT association_NN of_IN specific_JJ microorganisms_NNS with_IN symptoms_NNS TABLE_NP 4_CD |_SYM OR_JJ analysis_NN of_IN the_DT association_NN of_IN specific_JJ microorganisms_NNS with_IN history_NN of_IN diabetes_NN mellitus_NN In_IN this_DT study_NN both_CC universal_JJ and_CC specific_JJ PCR_NP primers_NNS targeting_VBG bacterial_JJ rDNAs_NNS were_VBD used_VBN to_TO investigate_VB the_DT prevalence_NN of_IN putative_JJ pathogenic_JJ bacteria_NNS in_IN root_NN canals_NNS with_IN necrotic_JJ pulp_NN ._SENT Furthermore_RB ,_, valuable_JJ initial_JJ findings_NNS on_IN the_DT potential_JJ association_NN of_IN certain_JJ organisms_NNS with_IN clinical_JJ symptoms_NNS or_CC the_DT presence_NN of_IN diabetes_NN were_VBD revealed_VBN ._SENT More_RBR extensive_JJ studies_NNS are_VBP needed_VBN to_TO provide_VB definitive_JJ conclusions_NNS on_IN the_DT association_NN of_IN root_NN canal_NN microorganisms_NNS with_IN these_DT and_CC other_JJ clinical_JJ variables_NNS ._SENT Two_CD specimens_NNS had_VBD no_DT identifiable_JJ bacterial_JJ DNA_NN ._SENT Both_DT were_VBD from_IN patients_NNS who_WP had_VBD a_DT history_NN of_IN a_DT traumatic_JJ injury_NN that_WDT occurred_VBD about_RB 6_CD months_NNS before_IN treatment_NN ._SENT For_IN these_DT two_CD patients_NNS ,_, the_DT pulp_NN was_VBD not_RB responsive_JJ ,_, the_DT patients_NNS were_VBD starting_VBG to_TO have_VB mild_JJ symptoms_NNS ,_, and_CC there_EX were_VBD periapical_JJ radiographic_JJ changes_NNS that_WDT were_VBD not_RB consistently_RB seen_VBN throughout_IN treatment_NN ._SENT It_PP is_VBZ conceivable_JJ that_IN at_IN the_DT time_NN of_IN treatment_NN bacteria_NNS had_VBD not_RB yet_RB invaded_VBD the_DT necrotic_JJ pulp_NN in_IN these_DT patients_NNS ._SENT None_NN of_IN the_DT other_JJ patients_NNS in_IN the_DT patient_JJ population_NN studied_VBD had_VBD a_DT similar_JJ clinical_JJ presentation_NN ._SENT Therefore_RB ,_, these_DT patients_NNS could_MD be_VB considered_VBN further_JJR controls_NNS for_IN the_DT adequacy_NN of_IN the_DT sampling_NN technique_NN used_VBD ._SENT The_DT proportion_NN of_IN specimens_NNS positive_JJ for_IN bacterial_JJ DNA_NN was_VBD 22_CD of_IN 24_CD (_( 92_CD %_NN )_) ._SENT This_DT was_VBD higher_JJR than_IN that_DT found_VBN in_IN a_DT recent_JJ report_NN ,_, in_IN which_WDT the_DT same_JJ universal_JJ bacterial_JJ primers_NNS were_VBD used_VBN but_CC yielded_VBN a_DT positive_JJ identification_NN for_IN only_RB 73_CD %_NN of_IN the_DT cases_NNS examined_VBD ._SENT Differences_NNS in_IN clinical_JJ diagnosis_NN ,_, sampling_NN ,_, DNA_NN extraction_NN ,_, or_CC PCR_NP techniques_NNS between_IN the_DT two_CD studies_NNS may_MD account_VB for_IN these_DT differences_NNS ._SENT In_IN this_DT study_NN ,_, Streptococcus_NP spp._NP were_VBD the_DT organisms_NNS most_RBS strongly_RB associated_VBN with_IN endodontic_JJ symptoms_NNS and_CC with_IN the_DT presence_NN of_IN swelling_VBG ._SENT This_DT finding_NN is_VBZ consistent_JJ with_IN those_DT of_IN some_DT previous_JJ studies_NNS but_CC not_RB others_NNS ._SENT F._NP nucleatum_NN was_VBD the_DT organism_NN most_RBS frequently_RB identified_VBN in_IN root_NN canals_NNS with_IN necrotic_JJ pulp_NN ._SENT This_DT organism_NN was_VBD found_VBN to_TO be_VB the_DT organism_NN that_WDT was_VBD the_DT most_RBS prevalent_JJ in_IN endodontic_JJ infections_NNS in_IN previous_JJ studies_NNS that_WDT have_VBP used_VBN both_DT culturing_VBG and_CC PCR_NP methodologies_NNS ._SENT It_PP was_VBD also_RB positively_RB associated_VBN with_IN the_DT presence_NN of_IN preoperative_JJ symptoms_NNS in_IN this_DT study_NN ,_, and_CC the_DT presence_NN of_IN the_DT combination_NN of_IN F._NP nucleatum_NP and_CC Streptococcus_NP spp._NP was_VBD significantly_RB associated_VBN with_IN the_DT presence_NN of_IN preoperative_JJ symptoms_NNS ._SENT F._NP nucleatum_NN was_VBD previously_RB shown_VBN to_TO increase_VB the_DT pathogenicities_NNS of_IN other_JJ organisms_NNS in_IN mixed_JJ culture_NN ,_, especially_RB those_DT of_IN P._NP gingivalis_NP and_CC P._NP intermedia_NN ._SENT P._NP gingivalis_NNS was_VBD identified_VBN in_IN only_RB two_CD specimens_NNS in_IN this_DT study_NN ._SENT Although_IN the_DT OR_JJ analysis_NN showed_VBD that_IN this_DT organism_NN was_VBD associated_VBN with_IN symptoms_NNS ,_, swelling_VBG ,_, and_CC diabetes_NN ,_, the_DT sample_NN is_VBZ too_RB small_JJ to_TO establish_VB any_DT definitive_JJ association_NN ._SENT This_DT organism_NN has_VBZ frequently_RB been_VBN associated_VBN with_IN severe_JJ endodontic_JJ symptoms_NNS ,_, and_CC its_PP$ pathogenicity_NN in_IN endodontic_JJ infections_NNS should_MD be_VB further_RBR investigated_VBN ._SENT In_IN this_DT study_NN ,_, 12_CD of_IN 22_CD samples_NNS (_( 55_CD %_NN )_) had_VBD one_CD or_CC more_JJR members_NNS of_IN the_DT black-pigmented_JJ gram-negative_JJ rods_NNS :_: P._NP endodontalis_NP ,_, P._NP gingivalis_NP ,_, P._NP intermedia_NP ,_, and_CC P._NP nigrescens_NNS ._SENT This_DT group_NN of_IN organisms_NNS has_VBZ long_RB been_VBN associated_VBN with_IN the_DT presence_NN of_IN endodontic_JJ symptoms_NNS ._SENT However_RB ,_, our_PP$ analysis_NN of_IN this_DT sample_NN revealed_VBD no_DT association_NN of_IN black-pigmented_JJ gram-negative_JJ rods_NNS with_IN symptoms_NNS (_( OR_NP =_SYM 0.75_CD )_) ._SENT In_IN a_DT recent_JJ study_NN ,_, in_IN which_WDT these_DT four_CD organisms_NNS were_VBD investigated_VBN ,_, one_CD or_CC more_JJR of_IN these_DT four_CD organisms_NNS were_VBD identified_VBN in_IN 59_CD %_NN of_IN the_DT specimens_NNS ._SENT In_IN that_DT study_NN ,_, it_PP was_VBD concluded_VBN that_IN black-pigmented_JJ organisms_NNS in_IN the_DT root_NN canal_NN were_VBD not_RB associated_VBN with_IN symptoms_NNS ,_, although_IN they_PP were_VBD very_RB prevalent_JJ in_IN pus_NN samples_NNS from_IN periapical_JJ abscesses_NNS ._SENT Only_RB one_CD sample_NN was_VBD positive_JJ for_IN P._NP intermedia_NN ,_, whereas_IN about_IN a_DT third_JJ of_IN the_DT samples_NNS were_VBD positive_JJ for_IN P._NP nigrescens_NNS ._SENT P._NP intermedia_NP is_VBZ an_DT organism_NN that_WDT has_VBZ frequently_RB been_VBN identified_VBN in_IN endodontic_JJ infections_NNS ._SENT However_RB ,_, more_RBR recently_RB it_PP was_VBD recognized_VBN that_IN this_DT organism_NN is_VBZ difficult_JJ to_TO differentiate_VB from_IN P._NP nigrescens_NNS by_IN traditional_JJ culturing_VBG methods_NNS but_CC that_IN the_DT two_CD are_VBP easily_RB distinguishable_JJ by_IN molecular_JJ techniques_NNS ._SENT Our_PP$ results_NNS confirm_VBP previous_JJ findings_NNS that_IN P._NP nigrescens_NNS is_VBZ more_RBR prevalent_JJ in_IN endodontic_JJ infections_NNS than_IN P._NP intermedia_NN ._SENT It_PP is_VBZ of_IN interest_NN that_IN B._NP forsythus_NP ,_, a_DT gram-negative_JJ rod_NN ,_, and_CC the_DT spirochete_NN T._NP denticola_NP were_VBD always_RB associated_VBN with_IN one_CD or_CC more_JJR members_NNS of_IN the_DT black-pigmented_JJ gram-negative_JJ rods_NNS ._SENT These_DT two_CD organisms_NNS (_( together_RB with_IN P._NP gingivalis_NNS )_) have_VBP been_VBN called_VBN the_DT "_`` red_JJ complex_NN "_'' bacteria_NNS because_IN of_IN their_PP$ strong_JJ association_NN with_IN severe_JJ forms_NNS of_IN periodontal_JJ disease_NN ._SENT Our_PP$ findings_NNS with_IN respect_NN to_TO these_DT organisms_NNS (_( except_IN for_IN P._NP gingivalis_NNS )_) agree_VBP with_IN those_DT in_IN a_DT recent_JJ report_NN in_IN that_WDT the_DT organisms_NNS do_VBP not_RB seem_VB to_TO be_VB associated_VBN with_IN symptomatic_JJ cases_NNS ._SENT A_DT recent_JJ report_NN indicated_VBD that_IN other_JJ oral_JJ treponemes_NNS such_JJ as_IN Treponema_NP maltophilum_NP and_CC Treponema_NP socranskii_NP ,_, which_WDT were_VBD not_RB included_VBN in_IN this_DT study_NN ,_, may_MD be_VB more_RBR prevalent_JJ in_IN endodontic_JJ infections_NNS than_IN T._NP denticola_NP ._SENT More_JJR studies_NNS are_VBP needed_VBN to_TO discern_VB the_DT contributions_NNS of_IN all_PDT these_DT organisms_NNS to_TO their_PP$ pathogenicities_NNS and_CC their_PP$ potential_JJ association_NN with_IN treatment_NN failure_NN ._SENT A_DT genus-specific_JJ primer_NN pair_NN that_WDT amplified_VBD a_DT unique_JJ sequence_NN in_IN the_DT Enterococcustuf_NP gene_NN was_VBD used_VBN to_TO detect_VB Enterococcus_NP spp._NP This_DT primer_NN pair_NN was_VBD shown_VBN to_TO detect_VB 14_CD of_IN 15_CD enterococcal_JJ species_NNS and_CC was_VBD negative_JJ with_IN 73_CD of_IN 79_CD other_JJ gram-positive_JJ and_CC gram-negative_JJ organisms_NNS tested_VBD ._SENT There_EX has_VBZ been_VBN a_DT recent_JJ increase_NN in_IN emphasis_NN on_IN the_DT presence_NN of_IN this_DT microorganism_NN in_IN association_NN with_IN failed_JJ endodontic_JJ treatment_NN ._SENT Enterococci_NNS are_VBP resistant_JJ to_TO calcium_NN hydroxide_NN ,_, which_WDT is_VBZ an_DT intracanal_JJ medicament_NN commonly_RB used_VBN in_IN patients_NNS with_IN pulp_NN necrosis_NN ._SENT E._NP faecalis_NP and_CC Enterococcus_NP faecium_NN are_VBP the_DT common_JJ isolates_NNS in_IN these_DT cases_NNS ._SENT Only_RB three_CD specimens_NNS in_IN the_DT present_JJ study_NN had_VBD Enterococcus_NP ,_, one_CD of_IN which_WDT had_VBD it_PP as_IN the_DT only_JJ organism_NN ._SENT Bacterial_JJ combinations_NNS in_IN root_NN canals_NNS may_MD be_VB more_RBR pathogenic_JJ than_IN individual_JJ strains_NNS ._SENT Therefore_RB ,_, it_PP is_VBZ important_JJ to_TO determine_VB the_DT association_NN of_IN bacterial_JJ combinations_NNS with_IN clinical_JJ signs_NNS and_CC symptoms_NNS or_CC treatment_NN outcome_NN ,_, as_RB well_RB as_IN the_DT association_NN of_IN certain_JJ microorganisms_NNS with_IN each_DT other_JJ ._SENT In_IN addition_NN to_TO the_DT association_NN of_IN the_DT combination_NN of_IN F._NP nucleatum_NP and_CC Streptococcus_NP spp._NP with_IN symptoms_NNS ,_, discussed_VBN before_IN ,_, certain_JJ other_JJ trends_NNS in_IN bacterial_JJ associations_NNS were_VBD evident_JJ ._SENT Table_NN shows_VBZ the_DT OR_JJ extremes_NNS infinity_NN and_CC 0_CD for_IN a_DT number_NN of_IN cases_NNS due_JJ to_TO the_DT high_JJ prevalence_NN of_IN some_DT organisms_NNS (_( e.g._FW ,_, F._NP nucleatum_NP )_) or_CC the_DT paucity_NN of_IN others_NNS (_( e.g._FW ,_, P._NP intermedia_NP )_) ._SENT Because_IN of_IN the_DT small_JJ number_NN of_IN positive_JJ identifications_NNS in_IN a_DT number_NN of_IN cases_NNS and_CC the_DT relatively_RB small_JJ overall_JJ sample_NN size_NN ,_, these_DT data_NNS are_VBP presented_VBN because_IN they_PP reveal_VBP possible_JJ trends_NNS and_CC should_MD be_VB further_RBR investigated_VBN ._SENT The_DT cloning_VBG and_CC sequencing_VBG of_IN amplicons_NNS from_IN one_CD specimen_NN obtained_VBN by_IN PCR_NP with_IN universal_JJ primers_NNS specific_JJ for_IN bacterial_JJ 16S_JJ rDNA_NN yielded_VBD the_DT sequence_NN of_IN an_DT organism_NN that_WDT has_VBZ not_RB hitherto_RB been_VBN described_VBN in_IN the_DT root_NN canal_NN environment_NN ._SENT Although_IN the_DT sequence_NN is_VBZ associated_VBN with_IN the_DT Olsenella_NP clade_NN by_IN neighbor-joining_VBG analysis_NN ,_, it_PP is_VBZ divergent_JJ from_IN known_JJ sequences_NNS and_CC may_MD be_VB either_RB a_DT new_JJ species_NN of_IN Olsenella_NP or_CC a_DT new_JJ genus_NN of_IN bacterium_NN that_WDT is_VBZ related_VBN to_TO Olsenella_NP ._SENT The_DT association_NN of_IN specimen_NN SP05_NP with_IN the_DT Olsenella_NP sequences_NNS is_VBZ supported_VBN by_IN a_DT relatively_RB weak_JJ bootstrap_NN value_NN of_IN 75_CD ._SENT Olsenella_NP uli_NNS was_VBD recently_RB shown_VBN to_TO be_VB present_JJ in_IN the_DT subgingival_JJ flora_NN of_IN patients_NNS with_IN refractory_JJ periodonti_NNS 